title: Massive ascites in a canakinumab resistant case with MVA leading to bone marrow transplantation.
authors.affiliation: Division of Metabolism, Department of Pediatrics, Uludag University Faculty of Medicine, 16059, Gorukle, Bursa, Turkey. dr_sahinerdol@hotmail.com.
authors.forename: Sahin
authors.identifier: http://orcid.org/0000-0003-4402-9609
authors.initials: S
authors.lastname: Erdol
authors.affiliation: Division of Immunology, Department of Pediatrics, Uludag University Faculty of Medicine, Bursa, Turkey.
authors.forename: Sukru
authors.initials: S
authors.lastname: Cekic
authors.affiliation: Division of Hematology, Department of Pediatrics, Medical Park Hospital, Istanbul, Turkey.
authors.forename: Suar Cakı
authors.initials: SC
authors.lastname: Kılıc
authors.affiliation: Division of Metabolism, Department of Pediatrics, Uludag University Faculty of Medicine, 16059, Gorukle, Bursa, Turkey.
authors.forename: Halil
authors.initials: H
authors.lastname: Saglam
authors.affiliation: Division of Immunology, Department of Pediatrics, Uludag University Faculty of Medicine, Bursa, Turkey.
authors.forename: Sara Sebnem
authors.initials: SS
authors.lastname: Kılıc
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001201:Ascites / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D004351:Drug Resistance; D017809:Fatal Outcome; D006801:Humans; D007223:Infant; D008297:Male; D054078:Mevalonate Kinase Deficiency / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D018805:Sepsis / Q000209:etiology; D013997:Time Factors; D017211:Treatment Failure
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C541220:canakinumab